SCHEMBL13618128

SCHEMBL13618128

COC(=O)[C@H](O)CNC(=O)OCc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
HTT P42858 1/20 0.52
CTSS P25774 3/20 0.52
CTSL P07711 2/20 0.52
SYK P43405 1/20 0.51
ALDH1A1 P00352 2/20 0.49
TRPM8 Q7Z2W7 1/20 0.49
ALOX15 P16050 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
CTSK P43235 3/20 0.48
KYNU Q16719 1/20 0.48
CTSB P07858 1/20 0.48
MAPT P10636 1/20 0.48
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
KMT2A Q03164 1/20 0.47
TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2525365 1.00 LMNA (0.55) LMNASMN1; SMN2HTTCTSSCTSL
SCHEMBL2525369 1.00 LMNA (0.55) LMNASMN1; SMN2HTTCTSSCTSL
SCHEMBL14617628 0.88 LMNA (0.55) LMNASMN1; SMN2HTTCTSSCTSL
SCHEMBL2142734 0.88 LMNA (0.58) LMNASMN1; SMN2HTTCTSSCTSL
SCHEMBL3701587 0.88 LMNA (0.58) LMNASMN1; SMN2HTTCTSSCTSL
SCHEMBL2646824 0.88 LMNA (0.58) LMNASMN1; SMN2HTTCTSSCTSL
SCHEMBL16533444 0.85 LMNA (0.60) LMNASMN1; SMN2HTTL3MBTL1MAPT
SCHEMBL8274264 0.85 LMNA (0.56) LMNASMN1; SMN2HTTCTSSCTSL
SCHEMBL8132360 0.85 CTSS (0.53) LMNASMN1; SMN2HTTCTSSCTSL
SCHEMBL8274278 0.85 LMNA (0.56) LMNASMN1; SMN2HTTCTSSCTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090286875-A1 ISOCYSTENE DERIVATIVES FOR THE TREATMENT OF PAIN PFIZER, INC. (US) 2009-11-19 US disclosed
US-20090286875-A1 ISOCYSTENE DERIVATIVES FOR THE TREATMENT OF PAIN PFIZER, INC. (US) 2009-11-19 US disclosed
US-20090227680-A1 Amino Acid Derivatives PFIZER, INC. (US) 2009-09-10 US disclosed
US-20090227680-A1 Amino Acid Derivatives PFIZER, INC. (US) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227680-A1 Amino Acid Derivatives OPRL1, OPRK1, AVPR1A LMNA 3623/4885SMN1; SMN2 1720/4885HTT 1869/4885
US-20090286875-A1 ISOCYSTENE DERIVATIVES FOR THE TREATMENT OF PAIN IDH3A, ACHE, SDHA LMNA 3329/4885SMN1; SMN2 1529/4885HTT 1291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.